Search
Dexamethasone Treatment Options in United Kingdom
A collection of 187 research studies where Dexamethasone is the interventional treatment. These studies are located in the United Kingdom . Dexamethasone is used for conditions such as Multiple Myeloma, Postoperative Pain and Lymphoma.
13 - 24 of 187
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Active Not Recruiting
The purpose of this study to determine if the addition of daratumumab to bortezomib + lenalidomide + dexamethasone (VRd) will improve overall minimal residual disease (MRD) negativity rate compared with VRd alone.
The purpose of this study to determine if the addition of daratumumab to bortezomib + lenalidomide + dexamethasone (VRd) will improve overall minimal residual disease (MRD) negativity rate compared with VRd alone. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/14/2025
Locations: Innovative Clinical Research Inc, Cerritos, California +113 locations
Innovative Clinical Research Inc, Cerritos, California
Baptist MD Anderson, Jacksonville, Florida
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana
Norton Healthcare, Louisville, Kentucky
Tufts Medical Center, Boston, Massachusetts
Boston University Medical Center, Boston, Massachusetts
Cancer And Hematology Centers of Western Michigan PC, Grand Rapids, Michigan
Saint Lukes Hospital Saint Lukes Cancer Specialists, Kansas City, Missouri
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
San Juan Oncology Associates, Farmington, New Mexico
Roswell Park Cancer Institute, Buffalo, New York
NYU Winthrop, Mineola, New York
Levine Cancer Institute, Charlotte, North Carolina
Cleveland Clinic, Cleveland, Ohio
Good Samaritan Hospital Corvallis, Corvallis, Oregon
University Of Pittsburgh Medical Center UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
Gibbs Cancer Center, Spartanburg, South Carolina
University of Texas, MD Anderson Cancer Center, Houston, Texas
University of Virginia, Charlottesville, Virginia
Universidade Estadual De Campinas, Campinas, Not set
Liga Norte Riograndense Contra O Cancer, Natal, Not set
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS, Porto Alegre, Not set
Ministerio da Saude Instituto Nacional do Cancer, Rio de Janeiro, Not set
Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro, Not set
Instituto de Ensino e Pesquisa São Lucas, Sao Paulo, Not set
Real e Benemerita Associacao Portuguesa de Beneficencia, Sao Paulo, Not set
Instituto Brasileiro de Controle do Cancer - Sao Camilo Oncologia, Sao Paulo, Not set
Clinica Medica Sao Germano S/S LTDA, Sao Paulo, Not set
Hospital Santa Cruz, São Paulo, Not set
Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta
Cross Cancer Institute, Edmonton, Alberta
The Gordon & Leslie Diamond Health Care Center, Vancouver, British Columbia
QEII Health Sciences Centre, Halifax, Nova Scotia
Brampton Civic Hospital, Brampton, Ontario
Victoria Hospital, London, Ontario
Lakeridge Health Oshawa, Oshawa, Ontario
McGill University Health Centre, Montreal, Quebec
CHU de Quebec L Hotel Dieu de Quebec, Quebec, Not set
Fakultni nemocnice Brno, Brno, Not set
Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set
Fakultni Nemocnice Ostrava, Ostrava, Not set
Fakultni nemocnice Plzen, Hemato-onkologicke oddeleni, Plzen, Not set
Vseobecna fakultni nemocnice v Praze, Praha 2, Not set
CHU Henri Mondor, Creteil N/a, Not set
Centre Hospitalier Départmental La Roche sur Yon, La Roche sur Yon Cedex 9, Not set
Hopital Claude Huriez, Lille, Not set
Institut Paoli Calmettes, Marseille Cedex 9, Not set
CHU de Montpellier Hopital Saint Eloi, Montpellier, Not set
CHU de Bordeaux - Hospital Haut-Leveque, Pessac cedex, Not set
Strasbourg Oncologie Libérale, Strasbourg, Not set
Institut Universitaire du cancer de Toulouse-Oncopole, Toulouse cedex 9, Not set
phase 3 - Hämatoonkologischer Studienkreis am Klinikum Aschaffenburg, Aschaffenburg, Not set
Universitatsklinikum Freiburg, Freiburg, Not set
St. Josef-Krankenhaus Hamm-Bockum-Hövel, Hamm, Not set
Institut für Versorgungsforschung, Koblenz, Not set
Universitatsmedizin Leipzig, Leipzig, Not set
Klinikum Großhadern der Ludwig-Maximilians-Universität, München, Not set
Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II,, Tuebingen, Not set
Barzilai Medical Center, Ashkelon, Not set
Hillel Yaffe Medical Center, Hadera, Not set
Rambam Med.Center - Hematology Institute, Haifa, Not set
Carmel Medical Center, Haifa, Not set
Meir Hospital, Kfar Saba, Not set
Rabin Medical Center, Petah-Tiqva, Not set
Sheba Medical Center, Ramat Gan, Not set
Sourasky (Ichilov) Medical Center, Tel Aviv, Not set
Fukuoka University Hospital, Fukuoka, Not set
Ogaki Municipal Hospital, Gifu, Not set
Kanazawa University Hospital, Kanazawa, Not set
Kobe City Medical Center General Hospital, Kobe City, Not set
National Hospital Organization Kumamoto Medical Center, Kumamoto shi, Not set
University Hospital Kyoto Prefectural University of Medicine, Kyoto, Not set
National Hospital Organization Matsumoto Medical Center, Matsumoto, Not set
Matsuyama Red Cross Hospital, Matsuyama, Not set
Nagoya City University Hospital, Nagoya, Not set
National Hospital Organization Okayama Medical Center, Okayama, Not set
Japanese Red Cross Osaka Hospital, Osaka, Not set
National Hospital Organization Shibukawa Medical Center, Shibukawa, Not set
Japanese Red Cross Medical Center, Shibuya, Not set
VU Medisch Centrum, Amsterdam, Not set
Albert Schweitzer ziekenhuis-lokatie Dordwijk, Dordrecht, Not set
Erasmus MC, Rotterdam, Not set
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, Not set
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzow, Not set
Uniwersyteckie Centrum Kliniczne, Gdansk, Not set
Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach, Kielce, Not set
NSSU Szpital Uniwersytecki w Krakowie, Krakow, Not set
Centrum Onkologii Ziemi Lubelskiej im sw Jana z Dukli, Lublin, Not set
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan, Not set
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Slupsk, Not set
Instytut Hematologii i Transfuzjologii, Warszawa, Not set
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warszawa, Not set
Hosp. Univ. Fundacion Alcorcon, Alcorcon, Not set
Hosp. Del Mar, Barcelona, Not set
Hosp. Univ. de Guadalajara, Guadalajara, Not set
Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda, Not set
Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcon, Not set
Hosp. Mutua Terrassa, Terrassa, Not set
Gulhane Egitim ve Arastirma Hastanesi, Ankara, Not set
Hacettepe University Medical Faculty, Ankara, Not set
Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Not set
Ankara University School of Medicine Cebeci Hospital, Ankara, Not set
Istanbul University Istanbul Medical Faculty, Istanbul, Not set
Dokuz Eylul University Medical Faculty, Izmir, Not set
Ondokuz Mayis University, Samsun, Not set
Monklands District General Hospital, Airdrie, Not set
Blackpool Victoria Hospital, Blackpool, Not set
University Hospital Wales, Cardiff, Not set
Colchester Hospital University NHS, Colchester, Not set
Leicester Royal Infirmary - Haematology, Leicester, Not set
Altnagelvin Hospital, Londonderry, Not set
The Royal Oldham Hospital, Oldham, Not set
Derriford Hospital, Plymouth, Not set
New Cross Hospital, Wolverhampton, Not set
Conditions: Multiple Myeloma
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can come back (relapsed) or may not get better (refractory) with treatment. This is a study to determine change in disease symptoms of etentamig compared to standard available therapies in adult participants with relapsed/r... Read More
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can come back (relapsed) or may not get better (refractory) with treatment. This is a study to determine change in disease symptoms of etentamig compared to standard available therapies in adult participants with relapsed/refractory (R/R) MM.
Etentamig is an investigational drug being developed for the treatment of R/R MM. This study is broken into 2 Arms; Arm A and Arm B. In Arm A, participants will receive etentamig as a monotherapy. In Arm B, participants will receive the standard available therapy (SAT) identified by the Investigator during screening, in accordance with the local (or applicable) approved label, package insert, summary of product characteristics, and/or the institutional guidelines, as applicable. Around 380 adult participants with relapsed/refractory multiple myeloma will be enrolled at approximately 140 sites across the world.
In Arm A participants will receive etentamig as an infusion into the vein in 28 day cycles, during the 3.5 year study duration. In Arm B, participants will receive the SAT identified by the Investigator during screening, in accordance with the local (or applicable) approved label, package insert, summary of product characteristics, and/or the institutional guidelines, as applicable, during the 3.5 year study duration.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and questionnaires. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: University of Alabama at Birmingham - Main /ID# 261434, Birmingham, Alabama +156 locations
University of Alabama at Birmingham - Main /ID# 261434, Birmingham, Alabama
Mayo Clinic Hospital - Phoenix /ID# 263326, Phoenix, Arizona
Alta Bates Summit Medical Center for Research /ID# 261438, Berkeley, California
Providence - St. Jude Medical Center /ID# 262031, Fullerton, California
VA Loma Linda Healthcare System /ID# 261015, Loma Linda, California
Cedars-Sinai Medical Center /ID# 261008, Los Angeles, California
Mayo Clinic Hospital Jacksonville /ID# 263324, Jacksonville, Florida
Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 246230, Jacksonville, Florida
Winship Cancer Institute of Emory University /ID# 262525, Atlanta, Georgia
University of Illinois at Chicago /ID# 246349, Chicago, Illinois
Nancy W. Knowles Cancer Center /ID# 271361, Elmhurst, Illinois
Springfield Clinic /ID# 262266, Springfield, Illinois
Our Lady Of The Lake Regional Medical Center /ID# 272780, Baton Rouge, Louisiana
Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 263637, Bethesda, Maryland
Beth Israel Deaconess Medical Center /ID# 271535, Boston, Massachusetts
Dana-Farber Cancer Institute /ID# 261554, Boston, Massachusetts
Regents of the University of Michigan /ID# 261577, Ann Arbor, Michigan
Karmanos Cancer Institute - Detroit /ID# 266298, Detroit, Michigan
Henry Ford Hospital /ID# 262704, Detroit, Michigan
Barbara Ann Karmanos Cancer Institute - McLaren Greater Lansing /ID# 259891, Lansing, Michigan
Mayo Clinic - Rochester /ID# 246228, Rochester, Minnesota
University of Missouri Hospital /ID# 261553, Columbia, Missouri
New York Cancer & Blood Specialists - Bay Shore /ID# 261524, Bay Shore, New York
Eastchester Center for Cancer Care /ID# 262952, Bronx, New York
New York Cancer & Blood Specialists - Lake Success Medical Oncology /ID# 262953, New Hyde Park, New York
New York Cancer and Blood Specialists - New York /ID# 262951, New York, New York
University of North Carolina /ID# 259854, Chapel Hill, North Carolina
Levine Cancer Institute /ID# 246199, Charlotte, North Carolina
Duke University Medical Center /ID# 259694, Durham, North Carolina
University Of Cincinnati Medical Center /ID# 246415, Cincinnati, Ohio
Cleveland Clinic Main Campus /ID# 246183, Cleveland, Ohio
Medical University of South Carolina /ID# 259692, Charleston, South Carolina
University of Tennessee Health Science Center /ID# 261622, Memphis, Tennessee
Baptist Memorial Hospital /ID# 270910, Memphis, Tennessee
The West Clinic /ID# 262444, Memphis, Tennessee
Vanderbilt University Medical Center /ID# 261621, Nashville, Tennessee
Virginia Cancer Specialists - Fairfax /ID# 262792, Fairfax, Virginia
VCU Massey Cancer Center: Dalton Oncology Clinic /ID# 261944, Richmond, Virginia
Northwest Medical Specialties Tacoma /ID# 276281, Tacoma, Washington
St George Hospital /ID# 261806, Kogarah, New South Wales
Liverpool Hospital /ID# 262159, Liverpool, New South Wales
Calvary Mater Newcastle /ID# 261804, Waratah, New South Wales
Princess Alexandra Hospital /ID# 261810, Woolloongabba, Queensland
Monash Health - Monash Medical Centre /ID# 262158, Clayton, Victoria
St Vincent's Hospital Melbourne /ID# 261808, Fitzroy Melbourne, Victoria
Box Hill Hospital /ID# 262784, Melbourne, Victoria
Universitaetsklinikum Krems /ID# 261509, Krems an der Donau, Niederoesterreich
Ordensklinikum Linz GmbH Elisabethinen /ID# 245609, Linz, Oberoesterreich
Medizinische Universitaet Graz /ID# 261908, Graz, Steiermark
Klinik Ottakring /ID# 245829, Vienna, Wien
Algemeen Ziekenhuis klina /ID# 260856, Brasschaat, Antwerpen
AZ Sint-Jan Brugge /ID# 245345, Brugge, West-Vlaanderen
University Health Network_Princess Margaret Cancer Centre /ID# 261566, Toronto, Ontario
Beijing Chaoyang Hospital,Capital Medical University /ID# 245533, Beijing, Beijing
Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 245545, Beijing, Beijing
Fujian Medical University Union Hospital /ID# 245558, Fuzhou, Fujian
Sun Yat-Sen University Cancer Center /ID# 245542, Guangzhou, Guangdong
People's Hospital of Henan Province /ID# 260918, Zhengzhou, Henan
Henan Cancer Hospital /ID# 245536, Zhengzhou, Henan
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 245549, Wuhan, Hubei
Zhongda Hospital Southeast University /ID# 245563, Nanjing, Jiangsu
The First Affiliated Hospital of Soochow University /ID# 245544, Suzhou, Jiangsu
The First Affiliated Hospital of Nanchang University /ID# 245537, Nanchang, Jiangxi
The First Hospital of China Medical University /ID# 245547, Shenyang, Liaoning
Second Affiliated Hospital of Xian Jiaotong University /ID# 261255, Xi'an, Shaanxi
Shanghai Tongji Hospital /ID# 245539, Shanghai, Shanghai
Institute of Hematology and Blood Diseases Hospital /ID# 265702, Tianjin, Tianjin
Tianjin Medical University General Hospital /ID# 260851, Tianjin, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 260883, Hangzhou, Zhejiang
Sir Run Run Shaw Hospital Zhejiang University School of Medicine /ID# 260882, Hangzhou, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University /ID# 245550, Wenzhou, Zhejiang
Fakultní Nemocnice Brno - Jihlavská /ID# 245689, Brno, Brno-mesto
Fakultní nemocnice Hradec Králové - Sokolská /ID# 245690, Hradec Králové, Hradec Kralove
Fakultni Nemocnice Ostrava /ID# 245686, Ostrava, Ostrava-mesto
Všeobecná Fakultní Nemocnice v Praze /ID# 245691, Praha, Praha 17
Odense University Hospital /ID# 260924, Odense, Syddanmark
Sygehus Lillebalt, Vejle /ID# 260923, Vejle, Syddanmark
Ch Saint Quentin /Id# 261856, St Quentin CEDEX, Aisne
Centre Hospitalier du Mans /ID# 261852, Le Mans CEDEX 9, Sarthe
CH Henri Duffaut /ID# 261844, Avignon CEDEX 9, Vaucluse
Centre Hospitalier Régional d'Orléans - Hôpital de la Source /ID# 261854, Orléans, Not set
Universitaetsklinikum Freiburg /ID# 262147, Freiburg, Baden-Wuerttemberg
Staedtisches Klinikum Karlsruhe /ID# 272377, Karlsruhe, Baden-Wuerttemberg
Klinikum Chemnitz - Flemmingstraße /ID# 273108, Chemnitz, Sachsen
Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 260689, Berlin, Not set
Centrum fuer Haematologie und Onkologie Bethanien /ID# 271982, Frankfurt am Main, Not set
Universitaetsklinikum Hamburg-Eppendorf /ID# 260651, Hamburg, Not set
Alexandra General Hospital /ID# 240591, Athens, Attiki
University General Hospital Attikon /ID# 240592, Athens, Attiki
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 240596, Athens, Not set
General University Hospital of Thessaloniki AXEPA /ID# 240595, Thessaloniki, Not set
Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 261648, Gyor, Gyor-Moson-Sopron
Semmelweis Egyetem /ID# 261647, Budapest, Not set
Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 261646, Budapest, Not set
The Chaim Sheba Medical Center /ID# 245497, Ramat Gan, Tel-Aviv
Tel Aviv Sourasky Medical Center /ID# 245495, Tel Aviv, Tel-Aviv
Shaare Zedek Medical Center /ID# 245681, Jerusalem, Yerushalayim
Rabin Medical Center /ID# 245498, Petah Tikva, Not set
ASST Ovest Milanese /ID# 256813, Legnano, Milano
A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 256808, Torino, Piemonte
Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 256810, Rome, Roma
Azienda Ospedaliero Universitaria delle Marche /ID# 256812, Ancona, Not set
AOU Policlinico G. Rodolico - San Marco /ID# 256814, Catania, Not set
Anjo Kosei Hospital /ID# 263434, Anjo, Aichi
Nagoya City University Hospital /ID# 263320, Nagoya, Aichi
Chiba University Hospital /ID# 262006, Chiba-shi, Chiba
University of Fukui Hospital /ID# 264222, Yoshida-gun, Fukui
Kyushu University Hospital /ID# 264704, Fukuoka-shi, Fukuoka
Gifu Municipal Hospital /ID# 263321, Gifu-shi, Gifu
Gunma University Hospital /ID# 262580, Maebashi-shi, Gunma
Chugoku Central Hospital /ID# 263431, Fukuyama, Hiroshima
Hyogo Prefectural Amagasaki General Medical Center /ID# 265696, Amagasaki, Hyogo
University Hospital Kyoto Prefectural University of Medicine /ID# 262585, Kyoto-shi, Kyoto
Miyagi Cancer Center /ID# 265094, Natori, Miyagi
Naha City Hospital /ID# 263972, Naha, Okinawa
The University of Osaka Hospital /ID# 263974, Suita-shi, Osaka
Saitama Prefectural Cancer Center /ID# 262586, Kitaadachi-gun, Saitama
Japanese Red Cross Medical Center /ID# 261717, Shibuya-ku, Tokyo
Seoul National University Hospital /ID# 245491, Seoul, Seoul Teugbyeolsi
Samsung Medical Center /ID# 245492, Seoul, Seoul Teugbyeolsi
The Catholic University of Korea, Seoul St. Marys Hospital /ID# 245493, Seoul, Seoul Teugbyeolsi
Ulsan University Hospital /ID# 245490, Ulsan, Ulsan Gwang Yeogsi
Yonsei University Health System Severance Hospital /ID# 245489, Seoul, Not set
Uniwersytecki Szpital Kliniczny We Wrocławiu /ID# 260172, Wroclaw, Dolnoslaskie
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie /ID# 260168, Lublin, Lubelskie
Uniwersyteckie Centrum Kliniczne /ID# 260169, Gdansk, Pomorskie
Fundacao Champalimaud /ID# 246258, Lisbon, Lisboa
Unidade Local de Saude de Santa Maria, EPE /ID# 246255, Lisboa, Not set
Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE /ID# 246257, Porto, Not set
Hematology And Oncology Institute /ID# 272531, Manati, Not set
Auxilio Mutuo Cancer Center /ID# 272565, San Juan, Not set
Alberts Cellular Therapy /ID# 245725, Pretoria, Gauteng
Constantiaberg Haematology /ID# 261320, Cape Town, Western Cape
Haemalife Inc. /ID# 245724, Kuilsrivier, Western Cape
Instituto Catalan de Oncologia (ICO) Badalona /ID# 246398, Badalona, Barcelona
Complejo Hospitalario Universitario Ourense /ID# 246400, Orense, Ourense
Hospital de Leon /ID# 261624, Leon, Not set
Hospital General Universitario Gregorio Maranon /ID# 246401, Madrid, Not set
Hospital Universitario de Salamanca /ID# 262218, Salamanca, Not set
Hospital Universitario y Politecnico La Fe /ID# 261625, Valencia, Not set
Helsingborgs Lasarett /ID# 262513, Helsingborg, Skane Lan
Uddevalla sjukhus /ID# 262034, Uddevalla, Vastra Gotalands Lan
Falu Lasarett /ID# 262231, Falun, Not set
National Taiwan University Hospital /ID# 245482, Taipei City, Taipei
China Medical University Hospital /ID# 245483, Taichung, Not set
Taichung Veterans General Hospital /ID# 261142, Taichung, Not set
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 261672, Ankara, Not set
Antalya Egitim Ve Arastirma Hastanesi /ID# 261674, Antalya, Not set
Trakya University Medical Facu /ID# 261673, Edirne, Istanbul, Not set
Istanbul Florence Nightingale Hospital /ID# 271543, Şişli, Not set
Addenbrooke's Hospital /ID# 261104, Cambridge, Cambridgeshire
Western General Hospital - NHS Lothian /ID# 261106, Edinburgh, Edinburgh, City Of
Dup_Guys and St Thomas NHS Foundation Trust - Guy's Hospital /ID# 262488, London, Greater London
Nottingham City Hospital /ID# 261105, Nottingham, Nottinghamshire
Leeds Teaching Hospitals NHS Trust /ID# 261101, Leeds, West Yorkshire
The Royal Marsden NHS Foundation Trust /ID# 262470, London, Not set
The Christie Hospital /ID# 261102, Manchester, Not set
Conditions: Multiple Myeloma
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Recruiting
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer).
This study is seeking participants who:
* Are 18 years of age or older and have MM.
* Have received treatments before for MM.
* Have MM that has returned or not responded to their most recent treatment.
Half of the participants will receive elranatamab. The other half of participants will receive a combination t... Read More
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer).
This study is seeking participants who:
* Are 18 years of age or older and have MM.
* Have received treatments before for MM.
* Have MM that has returned or not responded to their most recent treatment.
Half of the participants will receive elranatamab. The other half of participants will receive a combination therapy selected by the study doctor. The selected combination therapy will include 2 to 3 different medicines commonly used to treat MM.
Elranatamab will be given as a shot under the skin at the study clinic about once a week. This may change to a smaller number of shots later in the study.
The medicines in the combination therapy will be taken by mouth (at home or at the study clinic) AND will be given either as:
* a shot under the skin at the study clinic
* through a needle in the vein at the study clinic The number of times these medicines will be taken depends on what combination therapy the study doctor selects.
Participants may continue to receive elranatamab or a combination therapy until their MM is no longer responding. The study team will see how each participant is doing with the study treatment during regular visits at the study clinic. The study team will continue to follow-up with participants after study treatment with telephone contacts (or visits).
The study will compare the experiences of people receiving elranatamab to those people receiving a combination therapy. This will help learn about the safety and how effective elranatamab is. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/13/2025
Locations: Infirmary Cancer Care, Mobile, Alabama +229 locations
Infirmary Cancer Care, Mobile, Alabama
Western Regional Medical Center, Inc. dba. City of Hope Phoenix, Goodyear, Arizona
Beverly Hills Cancer Center, Beverly Hills, California
Community Cancer Institute, Clovis, California
Clinical Research Advisors (Encino Satellite Location), Encino, California
Hoag Health Center Irvine, Irvine, California
Hoag Hospital Irvine, Irvine, California
Clinical Research Advisors (Korea Town Satellite Location), Los Angeles, California
Clinical Research Advisors (West Hollywood Satellite Location), Los Angeles, California
Valkyrie Clinical Trials, Los Angeles, California
Hoag Memorial Hospital Presbyterian, Newport Beach, California
Mission Community Hospital (Satellite Site), Panorama City, California
University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento, California
University of California, Sacramento, California
UCHealth Poudre Valley Hospital, Fort Collins, Colorado
PET Imaging of Northern Colorado, Fort Collins, Colorado
UCHealth Harmony, Fort Collins, Colorado
UCHealth Greeley Hospital, Greeley, Colorado
UCHealth Longs Peak Hospital, Longmont, Colorado
UCHealth Longs Peak Medical Center, Longmont, Colorado
UCHealth - Medical Center of the Rockies, Loveland, Colorado
Baptist Hospital of Miami, Miami, Florida
BRCR Global, Plantation, Florida
BRCR Global - Tamarac, Tamarac, Florida
Midwestern Regional Medical Center, Inc. dba City of Hope Chicago, Zion, Illinois
Community Health Network, Inc., Indianapolis, Indiana
Community Health Network, Inc., Indianapolis, Indiana
Community Health Network, Inc., Indianapolis, Indiana
Beth Israel Deaconess Medical Center, Boston, Massachusetts
BIDMC Research Pharmacy, Boston, Massachusetts
Bryan Medical Center, Lincoln, Nebraska
NHO Revive Research Institute, LLC, Lincoln, Nebraska
Atlantic Health System Morristown Medical Center, Morristown, New Jersey
WMCHealth Advanced Physician Services, Hawthorne, New York
Cayuga Cancer Center at Cayuga Park, Ithaca, New York
Cayuga Medical Center, Ithaca, New York
Westchester Medical Center, Valhalla, New York
Brody school of Medicine at East Carolina University, Greenville, North Carolina
ECU Health Medical Center, Greenville, North Carolina
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
TriHealth Cancer Institute-Good Samaritan Hospital, Cincinnati, Ohio
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
The Jewish Hospital, Cincinnati, Ohio
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio
Cleveland Clinic, Cleveland, Ohio
AHN West Penn Hospital, Pittsburgh, Pennsylvania
Brown University Health Cancer Institute, Providence, Rhode Island
The Miriam Hospital, Providence, Rhode Island
St Francis Cancer Center, Greenville, South Carolina
Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy, Dallas, Texas
Baylor University Medical Center, Dallas, Texas
Houston Methodist Hospital, Houston, Texas
Houston Methodist Willowbrook Hospital, Houston, Texas
US Oncology Investigational Products Center (IPC), Irving, Texas
Houston Methodist Sugar Land Hospital, Sugar Land, Texas
Baylor Scott & White Medical Center - Temple, Temple, Texas
WVU Cancer Institute, Morgantown, West Virginia
University of Wisconsin Carbone Cancer Center-University Hospital, Madison, Wisconsin
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin
Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires
Hospital Universitario Austral, Pilar, Buenos Aires
Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Ciudad Autónoma DE Buenos Aires
Hospital Italiano de La Plata, La Plata, Not set
Blacktown Hospital, Blacktown, New South Wales
Concord Repatriation General Hospital, Concord, New South Wales
Sunshine Coast University Hospital, Birtinya, Queensland
Royal Brisbane and Women's Hospital, Brisbane, Queensland
St Vincent's Hospital (Melbourne), Fitzroy, Victoria
Barwon Health, Geelong, Victoria
Clinique Saint Pierre, Ottignies, Brabant Wallon
UZ Brussel, Brussels, Bruxelles-capitale, Région DE
Grand Hôpital de Charleroi, Gilly, Hainaut
Centre Hospitalier Epicura, Hornu, Hainaut
CHR Verviers - La Tourelle, Verviers, Liège
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi, Yvoir, Namur
UZ Gent, Gent, Oost-vlaanderen
AZ Delta vzw, Roeselare, West-vlaanderen
Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador, Salvador, Bahia
Instituto Oncomed de Educação e Pesquisa, Niterói, RIO DE Janeiro
Hospital Moinhos de Vento, Porto Alegre, RIO Grande DO SUL
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, RIO Grande DO SUL
Centro de Pesquisa Clínica - Área Administrativa, Porto Alegre, RIO Grande DO SUL
Hospital Mae de Deus, Porto Alegre, RIO Grande DO SUL
Hospital Amaral Carvalho, Jau, SÃO Paulo
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP), Ribeirão Preto, SÃO Paulo
Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, SÃO Paulo
Clínica Médica São Germano LTDA, SP, SÃO Paulo
Instituto de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, Not set
Americas Centro de Oncologia Integrado, Rio de Janeiro, Not set
Instituto de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, Not set
ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis, São Paulo, Not set
Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set
Hospital do Coracao, São Paulo, Not set
HU UNIFESP / SPDM - Hospital São Paulo, São Paulo, Not set
Universidade Federal de Sao Paulo, São Paulo, Not set
Clínica Médica São Germano S/S Ltda, São Paulo, Not set
Cross Cancer Institute, Edmonton, Alberta
The Moncton Hospital, Moncton, New Brunswick
Jewish General Hospital, Montreal, Quebec
Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎ, Montreal, Quebec
Klinicki bolnicki centar Rijeka, Rijeka, Not set
University Hospital Center Zagreb, Zagreb, Not set
Klinicka bolnica Dubrava, Zagreb, Not set
Klinicka bolnica Merkur, Zagreb, Not set
Fakultní nemocnice Brno Bohunice, Brno, Brno-město
Fakultni nemocnice Olomouc, Olomouc, Olomoucký KRAJ
Fakultni nemocnice Kralovske Vinohrady, Prague, Praha 10
Vseobecna fakultni nemocnice v Praze, Praha 2, Not set
Rigshospitalet, Copenhagen, Hovedstaden
Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland
Aalborg Universitetshospital, Syd, Aalborg, Nordjylland
Tampereen yliopistollinen sairaala, Tampere, Pirkanmaa
Oulun yliopistollinen sairaala, Oulu, Pohjois-pohjanmaa
Kuopion Yliopistollinen Sairaala, Kuopio, Pohjois-savo
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Uusimaa
Turku University Hospital, Turku, Varsinais-suomi
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice, Alpes-maritimes
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE, Toulouse, Haute-garonne
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandoeuvre lès Nancy, Lorraine
Centre Hospitalier de Dunkerque, Dunkirk, Nord-pas-de-calais
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes, Pays-de-la-loire
Hôpital NOVO, Cergy Pontoise, Val-d'oise
Hôpital NOVO, Pontoise, Val-d'oise
Henri Mondor Hospital, Créteil, Val-de-marne
CHD Vendee, La Roche-sur-Yon, Vendée
Centre Hospitalier de la Côte Basque, Bayonne, Not set
Centre Hospitalier du Mans, Le Mans, Not set
Hôpital Universitaire Necker Enfants Malades, Paris, Not set
Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set
Centre Hospitalier de Cornouaille, Quimper, Not set
Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau, Tours, Not set
Centre Hospitalier Bretagne Atlantique, Vannes, Not set
Centre Hospitalier Bretagne Atlantique, Vannes, Not set
Universitaetsklinikum Freiburg, Freiburg, Baden-württemberg
Robert Bosch Krankenhaus GmbH, Stuttgart, Baden-württemberg
Universitaetsklinikum Ulm, Ulm, Baden-württemberg
Klinikum Nürnberg Nord, Nürnberg, Bayern
Universitätsklinikum Bonn, Bonn, Nordrhein-westfalen
Universitätsklinikum Jena, Jena, Thüringen
Vivantes Klinikum Am Urban, Berlin, Not set
Vivantes Klinikum Am Urban, Berlin, Not set
Medizinische Universität Lausitz - Carl Thiem, Cottbus, Not set
Asklepios Altona, Hamburg, Not set
St. Barbara-Klinik Hamm-Heessen, Hamm, Not set
Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Not set
University Hospital of Alexandroupolis, Alexandroupolis, Anatolikí Makedonía KAI Thráki
Evangelismos General Hospital of Athens, Athens, Attikí
Alexandra General Hospital of Athens, Athens, Attikí
"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía
G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki
University Hospital of Ioannina, Ioannina, Ípeiros
Soroka Medical Center, Be'er Sheva, Hadarom
Rabin Medical Center, Petah-Tikva, Hamerkaz
Sheba Medical Center, Ramat Gan, Hamerkaz
Sourasky Medical Center, Tel Aviv, Tell Abīb
Hadassah Medical Center, Jerusalem, Yerushalayim
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-romagna
P.O. San Carlo Borromeo- ASST SANTI PAOLO E CARLO, Milano, Lombardia
Azienda Ospedaliero Universitaria delle Marche, Ancona, Marche
Azienda Socio Sanitaria Ovest milanese, Legnano, Milano
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Piemonte
A.O.U. Policlinico Paolo Giaccone, Palermo, Sicilia
Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana
Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set
Istituto Europeo di Oncologia IRCCS, Milano, Not set
Ospedale Civile dello Spirito Santo, Pescara, Not set
Nagoya City University Hospital, Nagoya, Aichi
Toyohashi Municipal Hospital, Toyohashi, Aichi
Ehime Prefectural Central Hospital, Matsuyama, Ehime
Ogaki Municipal Hospital, Ogaki, Gifu
Gunma University Hospital, Maebashi, Gunma
National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma
Kobe City Medical Center General Hospital, Kobe, Hyogo
Iwate Medical University Hospital, Shiwa-gun Yahaba-cho, Iwate
Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka
Nippon Medical School Hospital, Bunkyo-ku, Tokyo
Japanese Foundation for Cancer Research, Koto, Tokyo
Yamanashi Prefectural Central Hospital, Kofu-shi, Yamanashi
Kagoshima University Hospital, Kagoshima, Not set
University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set
National Hospital Organization Okayama Medical Center, Okayama, Not set
Okayama Rosai Hospital, Okayama, Not set
Yamagata University Hospital, Yamagata, Not set
Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [seoul]
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [seoul]
Maastricht UMC+, Maastricht, Limburg
Albert Schweitzer Ziekenhuis, locatie Dordwijk, Dordrecht, Zuid-holland
Akershus Universitetssykehus, Lørenskog, Akershus
St. Olavs Hospital, Trondheim, Sør-trøndelag
Sykehuset i Vestfold, Tønsberg, Vestfold
Oslo Universitetssykehus Ullevål, Oslo, Not set
2Ca Braga, Braga, Not set
Univerzitna nemocnica Martin, Martin, Zilinsky
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banska Bystrica, Not set
Institut Català d'Oncologia (ICO) - Badalona, Badalona, Barcelona [barcelona]
Hospital Universitari Mutua Terrassa, Terrassa, Barcelona [barcelona]
Hospital General Universitario Morales Meseguer, Murcia, Galicia [galicia]
Institut Català d'Oncologia (ICO) - Girona, Girona, Girona [gerona]
Hospital Universitario Infanta Leonor, Madrid, Madrid, Comunidad DE
OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces, Barakaldo, PAÍS Vasco
ASCIRES ECG Médica S.L, València, Valenciana, Comunitat
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Universitario HM Sanchinarro, Madrid, Not set
H.R.U Málaga - Hospital General, Málaga, Not set
Centro de Diagnóstico y Resonancia Magnética, Salamanca, Not set
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set
Hospital Universitari i Politecnic La Fe, València, Not set
Falu Lasarett, Falun, Not set
Universitetssjukhuset Örebro, Örebro, Örebro LÄN [se-18]
China Medical University Hospital, Taichung, Not set
Milton Keynes Hospital, Milton Keynes, Buckinghamshire
Glan Clwyd Hospital, Bodelwyddan, Denbighshire [SIR Ddinbych Gb-ddb]
Royal Bournemouth Hospital, Bournemouth, Dorset
Poole Hospital, Poole, Dorset
Eastbourne District General Hospital, Eastbourne, EAST Sussex
Queen Elizabeth Hospital Birmingham, Birmingham, England
Maidstone Hospital, Maidstone, Kent
St Bartholomew's Hospital, London, London, CITY OF
Guy's & St Thomas' NHS Foundation Trust, London, London, CITY OF
King's College Hospital, London, London, CITY OF
Hammersmith Hospital, London, London, CITY OF
Churchill Hospital, Oxford, Oxfordshire
Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire
Royal Marsden Hospital (Sutton), London, Sutton
Kent and Canterbury Hospital, Canterbury, Not set
New Cross Hospital, Wolverhampton, Not set
Conditions: Multiple Myeloma
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
Active Not Recruiting
This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the physician's choice of endocrine therapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer who have had previous treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) and endocrine therapy, either in the locally advanced/m... Read More
This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the physician's choice of endocrine therapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer who have had previous treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) and endocrine therapy, either in the locally advanced/metastatic or the adjuvant setting. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/12/2025
Locations: Alabama Oncology - Bruno Cancer Center, Birmingham, Alabama +170 locations
Alabama Oncology - Bruno Cancer Center, Birmingham, Alabama
Alaska Oncology & Hematology, LLC, Anchorage, Alaska
The Dignity Health Cancer Institute, Phoenix, Arizona
Arizona Oncology Associates, PC-CASA, Tucson, Arizona
Genesis Cancer Center, Hot Springs, Arkansas
University of Arkansas for Medical Sciences, Little Rock, Arkansas
Pacific Cancer Medical Center, Anaheim, California
Alta Bates Summit Medical Center, Berkeley, California
Beverly Hills Cancer Center, Beverly Hills, California
TOI Clinical Research, Cerritos, California
Newport Beach UC Irvine Medical Center, Costa Mesa, California
Women's Cancer Care, Fresno, California
Scripps Health, La Jolla, California
Los Angeles Hematology Oncology Medical Group, Los Angeles, California
University of California, Irvine Medical Center, Orange, California
Emad Ibrahim, Md, Inc, Redlands, California
Brian LeBerthon, Med Corp, West Covina, California
Yale Cancer Center, New Haven, Connecticut
Broward Health Medical Center (BHMC) (Broward General Medical Center (BGMC)), Fort Lauderdale, Florida
Mount Sinai Medical Center, Miami Beach, Florida
Orlando Health Cancer Institute, Orlando, Florida
Cancer Care Centers of Brevard, Palm Bay, Florida
Tampa General Hospital Cancer Institute, Tampa, Florida
Florida Cancer Specialists, West Palm Beach, Florida
Northwest Georgia Oncology Centers PC - Marietta, Marietta, Georgia
Summit Cancer Care PC, Savannah, Georgia
St Luke?s Cancer Institute, Boise, Idaho
Northwestern University, Chicago, Illinois
Springfield Clinic, Springfield, Illinois
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
Mission Cancer + Blood - IMMC, Des Moines, Iowa
University of Kansas Cancer Center, Westwood, Kansas
Pikeville Medical Center, Pikeville, Kentucky
Our Lady of the Lake Physicians Group, Baton Rouge, Louisiana
Woman's Hospital, Baton Rouge, Louisiana
Pontchartrain Cancer Center, Covington, Louisiana
Eastern Maine Medical Center, Brewer, Maine
New England Cancer Specialists, Scarborough, Maine
Anne Arundel Health System Research Institute, Annapolis, Maryland
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland
Mercy Medical Center, Baltimore, Maryland
Dana Farber Cancer Institute, Boston, Massachusetts
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center, Milford, Massachusetts
Metro-Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota
Oncology Hematology West PC, Grand Island, Nebraska
Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha, Nebraska
Renown Regional Medical Center, Reno, Nevada
Memorial Sloan Kettering - Basking Ridge, Basking Ridge, New Jersey
Summit Medical Group, Florham Park, New Jersey
Memorial Sloan Kettering - Monmouth, Middletown, New Jersey
Memorial Sloan-Kettering Cancer Center, Montvale, New Jersey
San Juan Oncology Associates, Farmington, New Mexico
Memorial Sloan Kettering, Commack, New York
Memorial Sloan Kettering Cancer Center at Westchester, Harrison, New York
Memorial Sloan Kettering Cancer Center, Long Island City, New York
The Blavatnik Family ? Chelsea Medical Center at Mount Sinai, New York, New York
Icahn School of Medicine at Mount Sinai, New York, New York
Icahn School of Medicine at Mount Sinai, New York, New York
Memorial Sloan-Kettering Cancer Center, New York, New York
Stony Brook University Medical Center, Stony Brook, New York
Memorial Sloan Kettering Cancer Center at Nassau, Uniondale, New York
SCRI Mark H. Zangmeister Center, Columbus, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma
St Charles Medical Center Bend, Bend, Oregon
Abramson Cancer Center, Philadelphia, Pennsylvania
UPMC Hillman Cancer Center - Magee-Women?s Hospital, Pittsburgh, Pennsylvania
Abramson Cancer Center Chester County Hospital, West Chester, Pennsylvania
McGlinn Cancer Institute at Reading Hospital, West Reading, Pennsylvania
Avera Cancer Institute, Sioux Falls, South Dakota
West Cancer Center, Germantown, Tennessee
Thompson Cancer Survival Center, Knoxville, Tennessee
Texas Oncology P.A - Beaumont, Beaumont, Texas
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Bedford, Texas
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas
Texas Oncology-Denton South, Denton, Texas
Texas Oncology, P.A. - El Paso, El Paso, Texas
Houston Methodist Cancer Center, Houston, Texas
Millennium Research & Clinical Development, Houston, Texas
Texas Oncology P.A., San Antonio, Texas
Inova Fairfax Hospital, Fairfax, Virginia
Virginia Cancer Specialists, Fairfax, Virginia
Virginia Oncology Associates, Norfolk, Virginia
Northwest Medical Specialties, PLLC, Tacoma, Washington
Instituto de Oncología Ángel H. Roffo, Agronomía, Ciudad Autónoma De BuenosAires
Fundación CENIT para la Investigación en Neurociencias, Recoleta, Ciudad Autónoma De BuenosAires
Consultorios Médicos Dr. Doreski, Ciudad Autonoma Buenos Aires, Not set
Centro Medico Privado CEMAIC, Cordoba, Not set
Fundacion Centro Oncologico de Integracion Regional (COIR), Mendoza, Not set
Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Not set
Sanatorio Parque S.A., Rosario, Not set
Hospital Provincial del Centenario, Rosario, Not set
Instituto de Oncologia de Rosario, Rosario, Not set
Centro Polivalente de Asistencia e Investigacion Clinica - CER San Juan, San Juan, Not set
Organizacion Medica de Investigacion, San Nicolás, Not set
Centro de Investigación Clínica ? Clínica Viedma, Viedma, Not set
Marienhospital Bottrop, Bottrop, Not set
Universitaetsklinikum Erlangen, Erlangen, Not set
Kliniken Essen-Mitte, Essen, Not set
Universitätsklinikum Heidelberg, Heidelberg, Not set
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Not set
Universitatsklinikum Munster, Münster, Not set
University of Athens, Hematological Clinic,, Athens, Not set
Attikon University General Hospital, Athens, Not set
Metropolitan General Hospital, Cholargos, Not set
University General Hospital of Heraklion, Heraklio, Not set
University General Hospital of Larissa, Larissa, Not set
IASO Obstetrics Gynecology Clinic, Marousi, Not set
Agios Loucas Clinic SA, Panorama, Not set
Olympion Clinic, Patras, Not set
University General Hospital of Patras, Patras, Not set
Metaxa Cancer Hospital of Piraeus, Peiraias, Not set
Interbalkan Medical Center of Thessaloniki, Thessaloniki, Not set
Euromedica PPDS, Thessaloniki, Not set
Azienda Ospedaliero - Universitaria di Modena Policlinico, Modena, Emilia-Romagna
Istituto Nazionale Tumori Regina Elena IRCCS, Roma, Lazio
Ospedale Policlinico San Martino, Genova, Liguria
Asst Grande Ospedale Metropolitano Niguarda, Milano, Lombardia
Azienda Ospedaliero Universitaria Ospedali Riuniti, Torrette Di Ancona, Marche
"Azienda Ospedaliera Universitaria Integrata Verona Ospedale Borgo Trento", Verona, Veneto
Aichi Cancer Center, Aichi, Not set
Nagoya University Hospital, Aichi, Not set
Chiba Cancer Center, Chiba, Not set
National Cancer Center Hospital East, Chiba, Not set
Shikoku Cancer Center, Ehime, Not set
Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Not set
Hiroshima University Hospital, Hiroshima, Not set
Hokkaido University Hospital, Hokkaido, Not set
Hyogo Cancer Center, Hyogo, Not set
University of Tsukuba Hospital, Ibaraki, Not set
Kanagawa Cancer Center, Kanagawa, Not set
Tokai University Hospital, Kanagawa, Not set
Kumamoto University Hospital, Kumamoto, Not set
Niigata Cancer Center Hospital, Niigata, Not set
National Hospital Organization Osaka National Hospital, Osaka, Not set
Juntendo University Hospital, Tokyo, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Chungbuk National University Hospital, Cheongju-si, Not set
Soon Chun Hyang University Cheonan Hospital, Dongnam-gu, Cheonan-si, Not set
National Cancer Center, Goyang-si, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System - PPDS, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
National University Hospital, Singapore, Not set
Oncocare Cancer Centre, Singapore, Not set
Rainbow Oncology Private Practice, Amanzimtoti, Not set
Hopelands Cancer Centre, Hilton, Not set
Medical Oncology Centre of Rosebank, Johannesburg, Not set
Complejo Hospitalario Universitario A Coruña (CHUAC, Materno Infantil), Oncología, La Coruña, LA Coruna
Hospital Dexeus, Barcelona, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
C.H. Regional Reina Sofia - PPDS, Cordoba, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Universitario Ramón y Cajal, Madrid, Not set
Hospital Clinico San Carlos, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital General Universitario J.M Morales Meseguer, Murcia, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Changhua Christian Hospital, Chang Hua, Not set
Chang Gung Memorial Hospital, Kaohsiung Country, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Not set
Chang Gung Memorial Hospital - Linkou Branch, Taipei, Not set
Memorial Ankara Hastanesi, Ankara, Not set
SAKARYA University Medical Faculty, Sakarya, Not set
Dorset County Hospital, Dorchester, Not set
North Middlesex Uni Hospital, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Nottingham City Hospital, Nottingham, Not set
Conditions: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
Active Not Recruiting
Multiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose of this study is to assess the safety and toxicity of ABBV-453 in adult participants with relapsed/refractory (R/R) MM. Adverse events and change in disease activity will be assessed.
ABBV-453 is an investigational drug being developed for the treatment of R/R MM. Part 1 will be a monotherapy dose escalation phase to determine the best dose of ABBV-453. In Part 2, pa... Read More
Multiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose of this study is to assess the safety and toxicity of ABBV-453 in adult participants with relapsed/refractory (R/R) MM. Adverse events and change in disease activity will be assessed.
ABBV-453 is an investigational drug being developed for the treatment of R/R MM. Part 1 will be a monotherapy dose escalation phase to determine the best dose of ABBV-453. In Part 2, participants are placed in 1 of 3 groups called treatment arms. Each group receives a different treatment. Approximately 28 to 48 adult participants in Part 1 and 150 to 312 adult participants in Part 2 with R/R MM will be enrolled in the study in approximately 70 sites worldwide.
In Part 1 and the Japan Cohort, Participants will receive oral ABBV-453 tablets once daily (QD) in 28-day cycles. In Part 2, Arm 1, participants will receive continuous doses of oral ABBV-453 tablets QD in combination with oral dexamethasone tablets once weekly in 28-day cycles. In Part 2, Arm 2, participants will receive continuous doses of oral ABBV-453 tablets QD in combination with subcutaneous injections of daratumumab every 1 to 4 weeks and oral dexamethasone tablets once weekly in, 28-day cycles. In Part 2, Arm 3, participants will receive continuous doses of oral ABBV-453 tablets QD in combination with subcutaneous injections of daratumumab every 1 to 4 weeks, oral lenalidomide capsules QD on Days 1-21, and oral dexamethasone tablets once weekly, in 28-day cycles.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at an approved institution (hospital or clinic). The effect of the treatment will be frequently checked by medical assessments, blood tests, and side effects. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/11/2025
Locations: Stanford University School of Med /ID# 242809, Stanford, California +20 locations
Stanford University School of Med /ID# 242809, Stanford, California
Sylvester Comprehensive Cancer Center /ID# 243417, Miami, Florida
Tulane University School of Medicine /ID# 244854, New Orleans, Louisiana
American Oncology Partners of Maryland /ID# 244858, Bethesda, Maryland
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 242754, Ann Arbor, Michigan
Mayo Clinic - Rochester /ID# 242844, Rochester, Minnesota
Memorial Sloan Kettering Cancer Center /ID# 243503, New York, New York
Atrium Health Levine Cancer Institute /ID# 243420, Charlotte, North Carolina
Duke Univ Med Ctr /ID# 242808, Durham, North Carolina
Wake Forest Baptist Health /ID# 244252, Winston Salem, North Carolina
University of Pennsylvania /ID# 242842, Philadelphia, Pennsylvania
Vanderbilt Ingram Cancer Center /ID# 242810, Nashville, Tennessee
Liverpool Hospital /ID# 244826, Liverpool, New South Wales
St Vincent's Hospital Melbourne /ID# 244827, Fitzroy Melbourne, Victoria
St. Vincent's Private Hospital Melbourne /ID# 262631, Fitzroy, Victoria
Austin Health and Ludwig Institute for Cancer Research /ID# 248311, Heidelberg, Victoria
Epworth Healthcare /ID# 248705, Richmond, Victoria
The Chaim Sheba Medical Center /ID# 250482, Ramat Gan, Tel-Aviv
Tel Aviv Sourasky Medical Center /ID# 250483, Tel Aviv, Tel-Aviv
Hadassah Medical Center-Hebrew University /ID# 250484, Jerusalem, Yerushalayim
Barts Health NHS Trust /ID# 248972, London, London, City of
Conditions: Relapsed/Refractory Multiple Myeloma
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Recruiting
The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd in participants with TI-NDMM.
The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd in participants with TI-NDMM. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/05/2025
Locations: GSK Investigational Site, Mobile, Alabama +76 locations
GSK Investigational Site, Mobile, Alabama
GSK Investigational Site, Kingwood, Texas
GSK Investigational Site, Capital Federal, Not set
GSK Investigational Site, Ciudad Autonoma de Buenos Aire, Not set
GSK Investigational Site, COrdoba, Not set
GSK Investigational Site, Rosario, Not set
GSK Investigational Site, Viedma, Not set
GSK Investigational Site, Gosford NSW, New South Wales
GSK Investigational Site, Box Hill, Victoria
GSK Investigational Site, Fitzroy, Not set
GSK Investigational Site, Brugge, Not set
GSK Investigational Site, Bruxelles, Not set
GSK Investigational Site, Gent, Not set
GSK Investigational Site, Hornu, Not set
GSK Investigational Site, Roeselare, Not set
GSK Investigational Site, Beijing, Not set
GSK Investigational Site, Guangzhou, Not set
GSK Investigational Site, Nanchang, Not set
GSK Investigational Site, Nanchang, Not set
GSK Investigational Site, Shanghia, Not set
GSK Investigational Site, Shenzhen, Not set
GSK Investigational Site, Tianjin, Not set
GSK Investigational Site, Wenzhou, Not set
GSK Investigational Site, Ostrava, Not set
GSK Investigational Site, Bobigny cedex, Not set
GSK Investigational Site, Nantes, Not set
GSK Investigational Site, Villejuif cedex, Not set
GSK Investigational Site, Alexandroupolis, Not set
GSK Investigational Site, Athens, Not set
GSK Investigational Site, Athens, Not set
GSK Investigational Site, Athens, Not set
GSK Investigational Site, Patra, Not set
GSK Investigational Site, Thessaloniki, Not set
GSK Investigational Site, Dublin 9, Not set
GSK Investigational Site, Waterford, Not set
GSK Investigational Site, Ancona, Not set
GSK Investigational Site, Meldola FC, Not set
GSK Investigational Site, Roma, Not set
GSK Investigational Site, Aichi, Not set
GSK Investigational Site, Ehime, Not set
GSK Investigational Site, Ehime, Not set
GSK Investigational Site, Fukuoka, Not set
GSK Investigational Site, Fukushima, Not set
GSK Investigational Site, Gunma, Not set
GSK Investigational Site, Hyogo, Not set
GSK Investigational Site, Hyogo, Not set
GSK Investigational Site, Ibaraki, Not set
GSK Investigational Site, Ishikawa, Not set
GSK Investigational Site, Iwate, Not set
GSK Investigational Site, Kanagawa, Not set
GSK Investigational Site, Miyagi, Not set
GSK Investigational Site, Nara, Not set
GSK Investigational Site, Sapporo, Not set
GSK Investigational Site, Suita, Not set
GSK Investigational Site, Tokyo, Not set
GSK Investigational Site, Yamagata, Not set
GSK Investigational Site, Hwasun, Not set
GSK Investigational Site, Jeonju, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Ulsan, Not set
GSK Investigational Site, Lublin, Not set
GSK Investigational Site, Badalona, Not set
GSK Investigational Site, Gijon, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Malaga, Not set
GSK Investigational Site, Murcia, Not set
GSK Investigational Site, Salamanca, Not set
GSK Investigational Site, Santander, Not set
GSK Investigational Site, Valladolid, Not set
GSK Investigational Site, Kaohsiung, Not set
GSK Investigational Site, Plymouth, Not set
Conditions: Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
Active Not Recruiting
The purpose of this trial is to measure the safety and effectiveness of epcoritamab (EPKINLY™), either by itself or together with other therapies, when treating participants with B-cell non-Hodgkin Lymphoma (B-NHL). The aim of the first part of the trial is to identify the most appropriate dose of epcoritamab, and the aim of the second part of the trial is to assess the selected epcoritamab dose in a larger group of participants with B-NHL. All participants in this trial will receive either epco... Read More
The purpose of this trial is to measure the safety and effectiveness of epcoritamab (EPKINLY™), either by itself or together with other therapies, when treating participants with B-cell non-Hodgkin Lymphoma (B-NHL). The aim of the first part of the trial is to identify the most appropriate dose of epcoritamab, and the aim of the second part of the trial is to assess the selected epcoritamab dose in a larger group of participants with B-NHL. All participants in this trial will receive either epcoritamab alone, or epcoritamab combined with another standard treatment regimen, with a total of 10 different treatment arms being studied.
Trial details include:
* The treatment duration for each participant depends upon which arm of treatment they are assigned to.
* The visit frequency for each participant depends upon which arm of treatment they are assigned to, but will be weekly to start for all participants, then will decrease to either: every 2 weeks, or every 3 weeks, or every 4 weeks, or every 8 weeks.
* All participants will receive active drug; no one will be given placebo.
Participants who receive treatment with epcoritamab will have it injected right under the skin. Participants will receive a different regimen of epcoritamab depending upon which arm of treatment they are assigned.
Participants who receive standard treatments will have intravenous (IV) infusions and/or oral administration of those treatments. Participants will receive a different standard treatment regimen depending upon which arm of treatment they are assigned. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/04/2025
Locations: University of Alabama at Birmingham, Birmingham, Alabama +57 locations
University of Alabama at Birmingham, Birmingham, Alabama
Cedars-Sinai Medical Center, Los Angeles, California
David Geffen School of Medicine at UCLA, Los Angeles, California
University of California San Francisco, San Francisco, California
Dana Farber Cancer Institute, Boston, Massachusetts
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
John Theurer Cancer Center at Hackensack UMC, Hackensack, New Jersey
Mount Sinai, New York, New York
Memorial Sloan Kettering CC, New York, New York
Levine Cancer Center, Charlotte, North Carolina
UT Southwestern Medical Center, Dallas, Texas
Austin Health, Heidelberg, Not set
Linear Clinical Research Limited, Nedlands, Not set
AZ Sint-Jan, Brugge, Not set
Universitair Ziekenhuis Gent, Gent, Not set
CHU UCL Namur Site Godinne, Yvoir, Not set
Fakultni nemocnice Hradec Kralove, Hradec Králové, Not set
Fakultni nemocnice Ostrava, Ostrava - Poruba, Not set
Fakultni nemocnice v Motole, Prague, Not set
Vseobecna Fakultni Nemocnice, Praha 2, Not set
Århus Hospital, Arhus, Not set
Rigshospitalet, Copenhagen, Not set
Odense University Hospital, Odense, Not set
Vejle Sygehus, Vejle, Not set
Tampere University Hospital, Helsinki, Not set
Kuopio University Hospital, Kuopio, Not set
HUS Cancer Center, Lahti, Not set
Hopital Claude Huriez - CHRU Lille, Lille, Not set
Hôpital de la Timone, Marseille, Not set
Hôpital Saint-Louis, Paris, Not set
Centre Hospitalier Lyon Sud, Pierre-Bénite, Not set
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII), Bergamo, Not set
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS, Bologna, Not set
Fondazione del Piemonte per l Oncologia Istituto di Candiolo IRCCS, Candiolo, Not set
Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Not set
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan, Not set
Fondazione IRCCS Policlinico San Matteo, Pavia, Not set
Arcispedale S. Maria Nuova Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Not set
Amsterdam UMC, Locatie VUMC, Amsterdam, Not set
Universitair Medisch Centrum Groningen (UMCG), Groningen, Not set
Leids Universitair Medisch Centrum, Leiden, Not set
Maastricht University Medical Center, Maastricht, Not set
Erasmus Medisch Centrum, Rotterdam, Not set
UMC Utrecht, Utrecht, Not set
Oslo Universitetssykehus HF, Radiumhospitalet, Oslo, Not set
ICO l Hospitalet, Barcelona, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario de Salamanca, Salamanca, Not set
Södra Älvsborgs Sjukhus, Borås, Not set
Sahlgrenska Sjukhuset, Göteborg, Not set
Skånes Universitetssjukhus, Lund, Not set
Karolinska Universitetssjukhuset, Solna, Not set
Akademiska Sjukhuset, Uppsala, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Freeman Hospital, Newcastle Upon Tyne, Not set
Derriford Hospital, Plymouth, Not set
Conditions: Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Open-Label Extension of EryDex Study IEDAT-04-2022
Recruiting
This is an international, multi-center, prospective, open-label, non-comparative study to provide EryDex treatment to ataxia telangiectasia (A-T) patients who complete the IEDAT-04-2022 trial on the neurological effects of EryDex on subjects with ataxia telangiectasia (NEAT trial).
This is an international, multi-center, prospective, open-label, non-comparative study to provide EryDex treatment to ataxia telangiectasia (A-T) patients who complete the IEDAT-04-2022 trial on the neurological effects of EryDex on subjects with ataxia telangiectasia (NEAT trial). Read Less
Gender:
ALL
Ages:
6 years and above
Trial Updated:
08/04/2025
Locations: University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence, Los Angeles, California +20 locations
University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence, Los Angeles, California
The Johns Hopkins Hospital, Division of pediatric allergy and immunology, Baltimore, Maryland
Biotrial Inc., Newark, New Jersey
Cincinnati Children's Hospital, Division of neurology, Cincinnati, Ohio
UT Health Houston, Department of pediatrics, division of child & adolescent neurology, Houston, Texas
Copenhagen University Hospital, Rigshospitalet, Department of Pediatric Neurology, Copenhagen, Not set
Tübingen University Hospital, Division Translational Genomics of Neurodegenerative Diseases, Tübingen, Bade-Würtenberg
IKF Pneumologie GmbH & Co. KG; Institut für klinische Forschung Pneumologie Clinical Research Center Respiratory Diseases, Frankfurt, Hesse
University Hospital Frankfurt, Pediatric and Adolescent Clinic, Frankfurt, Not set
Spedali Civili di Brescia, Pediatric immunology department, Brescia, Not set
Policlinico Umberto I, La sapienza University, Department of neurosciences and menthal health, Roma, Not set
Oslo University Hospital, Rikshospitalet, Division of Pediatric and Adolescent Medicine, Norwegian National Unit for Newborn Screening, Oslo, Not set
MedPolonia sp zoo, Poznań, Not set
Instytut "Pomnik-Centrum Zdrowia Dziecka", Immunology clinic, Warsaw, Not set
Hospital Universitari Vall d'Hebron, Department of pediatric neurology, Barcelona, Not set
Hospital Universitario La Paz, Department of pediatric neurology, Madrid, Not set
University Children's Hospital Zürich - Eleonore Foundation, Zürich, Not set
University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set
St George's University Hospitals NHS Foundation Trust, Centre for Neonatal and Paediatric Infection, London, Not set
Great Ormond Street Hospital for Children, Zayed Centre for Research, London, Not set
Nottingham Children's Hospital, Queen's Medical Center, Children's neurology, Nottingham, Not set
Conditions: Ataxia Telangiectasia
Evaluate the Neurological Effects of EryDex on Subjects With A-T
Active Not Recruiting
This is an international, multi-center, randomized, prospective, double-blind, placebo-controlled, Phase 3 study, designed to assess the effect of EryDex (dexamethasone sodium phosphate \[DSP\] in autologous erythrocytes), administered by intravenous (IV) infusion once every 28 days, on neurological symptoms of patients with Ataxia Telangiectasia (A-T).
This is an international, multi-center, randomized, prospective, double-blind, placebo-controlled, Phase 3 study, designed to assess the effect of EryDex (dexamethasone sodium phosphate \[DSP\] in autologous erythrocytes), administered by intravenous (IV) infusion once every 28 days, on neurological symptoms of patients with Ataxia Telangiectasia (A-T). Read Less
Gender:
ALL
Ages:
6 years and above
Trial Updated:
08/04/2025
Locations: University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence, Los Angeles, California +19 locations
University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence, Los Angeles, California
The Johns Hopkins Hospital, Division of pediatric allergy and immunology, Baltimore, Maryland
Cincinnati Children's Hospital, Division of neurology, Cincinnati, Ohio
UT Health Houston, Department of pediatrics, division of child & adolescent neurology, Houston, Texas
Copenhagen University Hospital, Rigshospitalet, Department of Pediatric Neurology, Copenhagen, Not set
Universitätsklinikum Tübingen Klinik für Kinder- und Jugendmedizin Kinderheilkunde III Neuropädiatrie, Allgemeinpädiatrie, Diabetologie, Endokrinologie, Sozialpädiatrie, Tübingen, Bade-Würtenberg
University Hospital Frankfurt, Pediatric and Adolescent Clinic, Frankfurt, Not set
IKF Pneumologie GmbH & Co. KG; Institut für klinische Forschung Pneumologie Clinical Research Center Respiratory Diseases, Frankfurt, Not set
Spedali Civili di Brescia, Pediatric immunology department, Brescia, Not set
Policlinico Umberto I, La sapienza University, Department of neurosciences and menthal health, Roma, Not set
Oslo University Hospital, Rikshospitalet, Division of Pediatric and Adolescent Medicine, Norwegian National Unit for Newborn Screening, Oslo, Not set
MedPolonia sp zoo, Poznań, Not set
Instytut "Pomnik-Centrum Zdrowia Dziecka", Immunology clinic, Warsaw, Not set
Hospital Universitari Vall d'Hebron, Department of pediatric neurology, Barcelona, Not set
Hospital Universitario La Paz, Department of pediatric neurology, Madrid, Not set
University Children's Hospital Zürich - Eleonore Foundation, Zürich, Not set
University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set
St George's University Hospitals NHS Foundation Trust, Centre for Neonatal and Paediatric Infection, London, Not set
Great Ormond Street Hospital for Children, Zayed Centre for Research, London, Not set
Nottingham Children's Hospital, Queen's Medical Center, Children's neurology, Nottingham, Not set
Conditions: Ataxia Telangiectasia
A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma
Completed
The purpose of this study is to determine if the addition of daratumumab to velcade (bortezomib) melphalan-prednisone (VMP) will prolong progression-free survival (PFS) compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy and autologous stem cell transplant (ASCT).
The purpose of this study is to determine if the addition of daratumumab to velcade (bortezomib) melphalan-prednisone (VMP) will prolong progression-free survival (PFS) compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy and autologous stem cell transplant (ASCT). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/04/2025
Locations: Not set, California City, California +163 locations
Not set, California City, California
Not set, Corona, California
Not set, Fountain Valley, California
Not set, Los Angeles, California
Not set, Hialeah, Florida
Not set, Orange Park, Florida
Not set, Chicago, Illinois
Not set, Springfield, Missouri
Not set, Cleveland, Ohio
Not set, Fredericksburg, Virginia
Not set, Buenos Aires, Not set
Not set, Ciudad Autonoma Buenos Aires, Not set
Not set, Córdoba, Not set
Not set, Santa Fe, Not set
Not set, Adelaide, Not set
Not set, Bendigo, Not set
Not set, Camperdown N/a, Not set
Not set, Geelong, Not set
Not set, Gosford, Not set
Not set, Greenslopes, Not set
Not set, Hobart, Not set
Not set, North Adelaide, Not set
Not set, Parkville, Not set
Not set, Antwerpen, Not set
Not set, Antwerp, Not set
Not set, Brussel, Not set
Not set, Charleroi, Not set
Not set, Gent, Not set
Not set, Kortrijk, Not set
Not set, Roeselare, Not set
Not set, Turnhout, Not set
Not set, Yvoir, Not set
Not set, Barretos, Not set
Not set, Cuiaba - Mount, Not set
Not set, Fortaleza, Not set
Not set, Goiania, Not set
Not set, Natal, Not set
Not set, Porto Alegre, Not set
Not set, Ribeirao Preto, Not set
Not set, Rio de Janeiro, Not set
Not set, Sao Paulo, Not set
Not set, Pleven, Not set
Not set, Plovdiv, Not set
Not set, Sofia, Not set
Not set, Varna, Not set
Not set, Vratsa, Not set
Not set, Zadar, Not set
Not set, Zagreb, Not set
Not set, Brno, Not set
Not set, Hradec Kralove, Not set
Not set, Olomouc, Not set
Not set, Ostrava-Poruba, Not set
Not set, Praha 10, Not set
Not set, Praha 2, Not set
Not set, Tbilisi, Not set
Not set, Berlin, Not set
Not set, Dortmund, Not set
Not set, Karlsruhe, Not set
Not set, Potsdam, Not set
Not set, Saarbrücken, Not set
Not set, Stuttgart, Not set
Not set, Würzburg, Not set
Not set, Athens Attica, Not set
Not set, Athens, Not set
Not set, Patra, Not set
Not set, Thessaloniki, Not set
Not set, Budapest, Not set
Not set, Debrecen, Not set
Not set, Kaposvar, Not set
Not set, Pecs N/a, Not set
Not set, Chiba, Not set
Not set, Hitachi, Not set
Not set, Kanazawa, Not set
Not set, Kawasaki, Not set
Not set, Kobe, Not set
Not set, Kurume, Not set
Not set, Matsuyama, Not set
Not set, Nagoya, Not set
Not set, Narita, Not set
Not set, Ohgaki, Not set
Not set, Okayama, Not set
Not set, Osaka, Not set
Not set, Sendai-shi, Not set
Not set, Shibukawa, Not set
Not set, Shibuya, Not set
Not set, Tachikawa, Not set
Not set, Toyohashi, Not set
Not set, Busan, Not set
Not set, Gyeonggi-do, Not set
Not set, Hwasun, Not set
Not set, Incheon, Not set
Not set, Seongnam, Not set
Not set, Seoul, Not set
Not set, Skopje, Not set
Not set, Bialystok, Not set
Not set, Bydgoszcz, Not set
Not set, Chorzow, Not set
Not set, Gdansk, Not set
Not set, Legnica, Not set
Not set, Lublin, Not set
Not set, Opole, Not set
Not set, Slupsk, Not set
Not set, Warszawa Ul, Not set
Not set, Warszawa, Not set
Not set, Wroclaw, Not set
Not set, Lisboa, Not set
Not set, Lisbon, Not set
Not set, Porto, Not set
Not set, Brasov, Not set
Not set, Bucharest, Not set
Not set, Iasi, Not set
Not set, Arkhangelsk, Not set
Not set, Dzerzhinsk, Not set
Not set, Ekaterinbourg, Not set
Not set, Nizhny Novgorod, Not set
Not set, Ryazan, Not set
Not set, Saint-Petersburg, Not set
Not set, Saratov, Not set
Not set, Sochi, Not set
Not set, St Petersburg, Not set
Not set, Volgograd, Not set
Not set, Belgrade, Not set
Not set, Nis, Not set
Not set, Novi Sad, Not set
Not set, Sremska Kamenica, Not set
Not set, Zemun, Not set
Not set, Andalucía, Not set
Not set, Badalona, Not set
Not set, Barcelona, Not set
Not set, Córdoba, Not set
Not set, Girona, Not set
Not set, La Laguna, Not set
Not set, Madrid, Not set
Not set, Maranon, Not set
Not set, Murcia N/a, Not set
Not set, Ourense, Not set
Not set, Pamplona, Not set
Not set, Salamanca, Not set
Not set, Sevilla, Not set
Not set, Toledo, Not set
Not set, Valencia, Not set
Not set, Zaragoza, Not set
Not set, Altindag, Not set
Not set, Ankara, Not set
Not set, Aydin, Not set
Not set, Izmir, Not set
Not set, Kayseri, Not set
Not set, Samsun, Not set
Not set, Tekirdag, Not set
Not set, Cherkassy, Not set
Not set, Dnepropetrovsk, Not set
Not set, Ivano-Frankivsk, Not set
Not set, Kharkov, Not set
Not set, Khmelnitskiy, Not set
Not set, Lviv, Not set
Not set, Zaporizhzhia, Not set
Not set, Birmingham, Not set
Not set, Cambridge, Not set
Not set, Colchester, Not set
Not set, Harlow, Not set
Not set, Leicester, Not set
Not set, London, Not set
Not set, Manchester, Not set
Not set, Woolwich, Not set
Conditions: Multiple Myeloma
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
Recruiting
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2.
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/31/2025
Locations: Local Institution - 0046, Mobile, Alabama +216 locations
Local Institution - 0046, Mobile, Alabama
Local Institution - 0005, Cerritos, California
Local Institution - 0190, Irvine, California
Local Institution - 0187, Los Angeles, California
Local Institution - 0344, Santa Rosa, California
Local Institution - 0339, Stockton, California
Local Institution - 0279, Newark, Delaware
Local Institution - 0341, Fort Myers, Florida
Local Institution - 0342, Saint Petersburg, Florida
Local Institution - 0340, West Palm Beach, Florida
Local Institution - 0348, Atlanta, Georgia
Local Institution - 0291, Atlanta, Georgia
Saint Alphonsus Regional Medical Center, Boise, Idaho
Local Institution - 0289, Annapolis, Maryland
Local Institution - 0204, Boston, Massachusetts
Local Institution - 0346, Minneapolis, Minnesota
Local Institution - 0222, Little Silver, New Jersey
Local Institution - 0199, Bronx, New York
University of North Carolina Medical Center, Chapel Hill, North Carolina
Local Institution - 0322, Cleveland, Ohio
Local Institution - 0172, Columbus, Ohio
Local Institution - 0321, Providence, Rhode Island
Charleston Oncology, P.A., Charleston, South Carolina
Local Institution - 0338, Greer, South Carolina
Local Institution - 0349, Chattanooga, Tennessee
Local Institution - 0323, Nashville, Tennessee
Local Institution - 0337, Fort Worth, Texas
Local Institution - 0328, Houston, Texas
Local Institution - 0044, Houston, Texas
Local Institution - 0195, Temple, Texas
Local Institution - 0345, Norfolk, Virginia
Local Institution - 0343, Roanoke, Virginia
Local Institution - 0006, Tacoma, Washington
Local Institution - 0347, Vancouver, Washington
Local Institution - 0243, Morgantown, West Virginia
Local Institution - 0336, Marshfield, Wisconsin
Local Institution - 0008, Ciudad Autónoma de Buenos Aires, Buenos Aires
Local Institution - 0079, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0182, Rosario, Santa Fe
Local Institution - 0319, San Miguel de Tucumán, Tucumán
Local Institution - 0150, Buenos Aires, Not set
Local Institution - 0151, Córdoba, Not set
Local Institution - 0077, Camperdown, New South Wales
Local Institution - 0160, Gosford, New South Wales
Local Institution - 0263, Port Macquarie, New South Wales
Local Institution - 0078, St Leonards, New South Wales
Local Institution - 0026, Sydney, New South Wales
Local Institution - 0024, Adelaide, South Australia
Local Institution - 0229, Hobart, Tasmania
Local Institution - 0131, Bendigo, Victoria
Local Institution - 0224, East Melbourne, Victoria
Local Institution - 0127, Heidelberg, Victoria
Local Institution - 0025, Melbourne, Victoria
Local Institution - 0266, Vienna, Wien
Local Institution - 0020, Linz, Not set
Local Institution - 0017, Wien, Not set
Local Institution - 0119, Wien, Not set
Local Institution - 0121, Salvador, Bahia
Local Institution - 0076, Porto Alegre, Rio Grande Do Sul
Local Institution - 0085, Sao Paulo, São Paulo
Local Institution - 0075, Rio de Janeiro, Not set
Local Institution - 0086, Rio de Janeiro, Not set
Local Institution - 0073, São Paulo, Not set
University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD, Plovdiv, Not set
Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda EAD, Sofia, Not set
UMHAT 'Sveti Ivan Rilsky', Sofia, Not set
Local Institution - 0183, Halifax, Nova Scotia
Local Institution - 0275, London, Ontario
Local Institution - 0184, Toronto, Ontario
Local Institution - 0186, Montreal, Quebec
Local Institution - 0318, Hefei, Anhui
Local Institution - 0057, Beijing City, Beijing
Local Institution - 0061, Beijing, Beijing
Local Institution - 0056, Beijing, Beijing
Local Institution - 0123, Fuzhou, Fujian
Local Institution - 0138, Guangzhou, Guangdong
Local Institution - 0315, Guangzhou, Guangdong
Local Institution - 0051, Zhengzhou, Henan
Local Institution - 0066, Wuhan, Hubei
Local Institution - 0054, Wuhan, Hubei
Local Institution - 0071, Changsha, Hunan
Local Institution - 0103, Changsha, Hunan
Local Institution - 0180, Nanjing, Jiangsu
Local Institution - 0111, Nantong, Jiangsu
Local Institution - 0104, Suzhou, Jiangsu
Local Institution - 0069, Wuxi, Jiangsu
Local Institution - 0095, Nanchang, Jiangxi
Local Institution - 0052, Changchun, Jilin
Local Institution - 0096, Shenyang, Liaoning
Local Institution - 0176, Shenyang, Liaoning
Local Institution - 0060, Xi'an, Shaanxi
Local Institution - 0072, Jinan, Shandong
Local Institution - 0118, Shanghai, Shanghai
Local Institution - 0317, Shanghai, Shanghai
Local Institution - 0091, Tianjing, Tianjin
Local Institution - 0058, Kunming, Yunnan
Local Institution - 0050, Hangzhou, Zhejiang
Local Institution - 0115, Wenzhou, Zhejiang
Local Institution - 0059, Taiyuan, Not set
Local Institution - 0153, Medellin, Antioquia
Local Institution - 0156, Valledupar, Cesar
Local Institution - 0154, Bogota, Cundinamarca
Local Institution - 0324, Piedecuesta, Santander
Local Institution - 0155, Cali, Not set
Local Institution - 0032, Aarhus, Midtjylland
Local Institution - 0065, Roskilde, Sjælland
Local Institution - 0129, Odense, Syddanmark
Local Institution - 0125, Vejle, Not set
Universitaetsklinikum Ulm, Ulm, Baden-Wurttemberg
Haematologie und Onkologie Muenchen-Pasing, Munich, Bayern
Klinikum Nuernberg Nord, Urologische Klinik, Nürnberg, Bayern
Praxis Onkologie am Raschplatz, Hannover, Niedersachsen
GEFOS Gesellschaft f. onkologische Studien, Dortmund, Nordrhein-Westfalen
Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein
Universitätsklinikum Jena, Jena, Thüringen
Charite Universitätsmedizin Berlin Campus Benjamin Franklin, Berlin, Not set
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Not set
Marien Hospital Düsseldorf, Düsseldorf, Not set
Universitaetsklinikum Heidelberg, Heidelberg, Not set
Local Institution - 0102, Köln, Not set
Universitätsklinikum Leipzig, Leipzig, Not set
Universitaetsklinikum Wuerzburg, Wuerzburg, Not set
Local Institution - 0136, Patras, Achaḯa
Local Institution - 0135, Athens, Attikí
Local Institution - 0134, Thessaloniki, Thessaloníki
Local Institution - 0178, Hksar, Not set
Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya
Debreceni Egyetem Klinikai Kozpont, Debrecen, Hajdú-Bihar
Szabolcs Szatmár Bereg Vármegyei Oktatókórház, Nyiregyhaza, Szabolcs-Szatmár-Bereg
Semmelweis Egyetem, Budapest, Not set
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Not set
Local Institution - 0170, New Delhi, Delhi
Local Institution - 0167, Gurgaon, Haryana
Local Institution - 0161, Bengaluru, Karnataka
Local Institution - 0168, Mumbai, Maharashtra
Local Institution - 0171, Thane, Maharashtra
Local Institution - 0261, Mohali, Punjab
Local Institution - 0174, Chennai, Tamil Nadu
Local Institution - 0165, Hyderabad, Telangana
Local Institution - 0310, Hyderabad, Telangana
Local Institution - 0164, Hyderabad, Telangana
Local Institution - 0230, Chandigarh, Not set
Local Institution - 0264, Holon, HaMerkaz
Local Institution - 0267, Zerifin, HaMerkaz
Local Institution - 0277, Jerusalem, Not set
Local Institution - 0145, Meldola, Emilia-Romagna
Local Institution - 0143, Milano, Lombardia
Local Institution - 0142, Rozzano, Milano
Local Institution - 0189, Bologna, Not set
Local Institution - 0148, Catanzaro, Not set
Local Institution - 0147, Lecce, Not set
Local Institution - 0144, Pisa, Not set
Local Institution - 0146, Udine, Not set
Local Institution - 0269, Nagoya, Aichi
Local Institution - 0214, Kashiwa, Chiba
Local Institution - 0210, Kitakyushu-shi, Fukuoka
Local Institution - 0211, Sapporo, Hokkaido
Local Institution - 0217, Higashiibaraki, Ibaraki
Local Institution - 0300, Kanazawa, Ishikawa
Local Institution - 0209, Shiwa-gun Yahaba-cho, Iwate
Local Institution - 0234, Kamakura, Kanagawa
Local Institution - 0225, Koshigaya, Saitama
Local Institution - 0236, Itabashiku, Tokyo
Local Institution - 0219, Koto-ku, Tokyo
Local Institution - 0303, Chuo, Yamanashi
Local Institution - 0215, Chiba, Not set
Local Institution - 0226, Fukuoka, Not set
Local Institution - 0235, Fukuoka, Not set
Local Institution - 0220, Kumamoto, Not set
University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set
Local Institution - 0213, Nagasaki, Not set
Local Institution - 0212, Okayama, Not set
Local Institution - 0301, Osaka, Not set
Local Institution - 0241, Tokyo, Not set
Local Institution - 0218, Tokyo, Not set
Local Institution - 0238, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0239, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0240, Seoul, Seoul-teukbyeolsi [Seoul]
Amphia Ziekenhuis, locatie Breda Molengracht, Breda, Noord-Brabant
Medisch Spectrum Twente, Enschede, Not set
Local Institution - 0049, Bergen, Hordaland
Local Institution - 0112, Stavanger, Rogaland
Local Institution - 0081, Oslo, Not set
Local Institution - 0316, San Juan, Not set
Fundeni Clinical Institute, Bucuresti, București
Local Institution - 0290, Timișoara, Timiș
Sc Onco Card Srl, Brasov, Not set
Affidea Fundeni, București, Not set
Spitalul Clinic Colțea, București, Not set
Spitalul Clinic Județean de Urgență Sibiu, Sibiu, Not set
Local Institution - 0158, Singapore, Central Singapore
Local Institution - 0159, Singapore, Central Singapore
Local Institution - 0126, Badalona, Barcelona [Barcelona]
Local Institution - 0092, Barcelona, Barcelona [Barcelona]
Local Institution - 0038, L'Hospitalet Del Llobregat, Barcelona [Barcelona]
Local Institution - 0200, Madrid, Madrid, Comunidad De
Local Institution - 0108, Majadahonda, Madrid, Comunidad De
Local Institution - 0192, San Cristobal de La laguna, Santa Cruz De Tenerife
Local Institution - 0201, San Cristobal de La laguna, Santa Cruz De Tenerife
Local Institution - 0037, Valencia, Valenciana, Comunitat
Local Institution - 0107, Granada, Not set
Local Institution - 0047, Madrid, Not set
Local Institution - 0105, Málaga, Not set
Local Institution - 0274, Chiayi City, Chiayi
Local Institution - 0177, Kaohsiung Niao Sung Dist, Kaohsiung
Local Institution - 0012, Kaohsiung, Not set
Local Institution - 0001, Taichung, Not set
Local Institution - 0002, Tainan, Not set
Local Institution - 0149, Taipei, Not set
Local Institution - 0162, Taipei, Not set
Local Institution - 0139, Plymouth, Devon
Local Institution - 0067, Cringleford, England
Local Institution - 0196, Glasgow, Glasgow City
Local Institution - 0039, Birmingham, Not set
Local Institution - 0273, Birmingham, Not set
Local Institution - 0080, Leeds, Not set
Local Institution - 0040, Taunton, Not set
Conditions: Relapsed or Refractory Multiple Myeloma
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Recruiting
The purpose of this study is to compare the efficacy and safety of mezigdomide (CC-92480), bortezomib and dexamethasone (MeziVd) versus pomalidomide, bortezomib and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines of therapy and who have had prior lenalidomide exposure.
The purpose of this study is to compare the efficacy and safety of mezigdomide (CC-92480), bortezomib and dexamethasone (MeziVd) versus pomalidomide, bortezomib and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines of therapy and who have had prior lenalidomide exposure. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/31/2025
Locations: Cancer and Blood Specialty Clinic, Los Alamitos, California +265 locations
Cancer and Blood Specialty Clinic, Los Alamitos, California
Sharp Memorial Hospital, San Diego, California
Local Institution - 0273, West Hollywood, California
Local Institution - 0381, Aurora, Colorado
UConn Health, Farmington, Connecticut
Local Institution - 0208, New Haven, Connecticut
Advanced Research, Coral Springs, Florida
Florida Cancer Specialists - South, Fort Myers, Florida
Florida Cancer Specialists - North, Saint Petersburg, Florida
Florida Cancer Specialists - East, West Palm Beach, Florida
University Cancer Blood Ctr, Athens, Georgia
Local Institution - 0048, Marietta, Georgia
Local Institution - 0330, Garden City, Kansas
University of Kansas Medical Center, Westwood, Kansas
Our Lady of the Lake RMC, Baton Rouge, Louisiana
Tulane Cancer Center, New Orleans, Louisiana
Local Institution - 0385, Shreveport, Louisiana
Sinai Hospital Of Baltimore, Baltimore, Maryland
Dana-Farber Cancer Institute, Boston, Massachusetts
University of Michigan, Ann Arbor, Michigan
Henry Ford Hospital, Detroit, Michigan
Minnesota Oncology Hematology, P.A., Minneapolis, Minnesota
Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi
Local Institution - 0242, Jackson, Mississippi
Astera Cancer Care, East Brunswick, New Jersey
Local Institution - 0363, Ridgewood, New Jersey
University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico
New York Cancer and Blood Specialists, Bronx, New York
Local Institution - 0245, Buffalo, New York
Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success, New York
New York Cancer and Blood Specialists, New Hyde Park, New York
New York Cancer and Blood Specialists, New York, New York
Rochester General Hospital, Rochester, New York
New York Cancer and Blood Specialists, Shirley, New York
Local Institution - 0274, Williamsville, New York
Duke Cancer Institute, Durham, North Carolina
Oncology Hematology Care, Cincinnati, Ohio
Fairview Hospital, Cleveland, Ohio
Cleveland Clinic, Cleveland, Ohio
Cleveland Clinic - Hillcrest Hospital, Mayfield Heights, Ohio
Lehigh Valley Health Network, Allentown, Pennsylvania
Local Institution - 0264, York, Pennsylvania
The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee
Texas Oncology - West Texas, Abilene, Texas
University of Texas MD Anderson Cancer Center, Houston, Texas
Mays Cancer Center, San Antonio, Texas
Texas Oncology - San Antonio, San Antonio, Texas
Utah Cancer Specialists, Salt Lake City, Utah
Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia
Virginia Oncology Associates, Norfolk, Virginia
Blue Ridge Cancer Care, Roanoke, Virginia
VA Puget Sound Health Care System, Seattle, Washington
Local Institution - 0293, Seattle, Washington
Local Institution - 0097, Spokane, Washington
Northwest Cancer Specialists, P.C., Vancouver, Washington
Local Institution - 0220, Madison, Wisconsin
Sanatorio Chivilcoy, Chivilcoy, Buenos Aires
Centro Medico Barrio Parque, Buenos Aires, Ciudad Autónoma De Buenos Aires
Hospital Privado Universitario de Córdoba, Cordoba, Córdoba
Clinica Viedma S. A, Viedma, R
Hospital Privado de Rosario, Rosario, Santa FE
Hospital Británico de Buenos Aires, Buenos Aires, Not set
Clínica de Nefrología, Urología y Enfermedades Cardiovasculares, Santa Fe, Not set
Liverpool Hospital, Liverpool, New South Wales
Calvary Mater Newcastle, Waratah, New South Wales
Wollongong Hospital-Illawarra Cancer Care Centre, Wollongong, New South Wales
Sunshine Coast University Hospital, Birtinya, Queensland
Box Hill Hospital, Box Hill, Victoria
The Alfred Hospital, Melbourne, Victoria
St Vincent's Hospital, Melbourne, Victoria
Sir Charles Gairdner Hospital, Nedlands, Western Australia
Klinik Ottakring, Vienna, Wien
Universitätsklinikum Krems, Krems an der Donau, Not set
LKH Hochsteiermark - Standort Leoben, Leoben, Not set
Universitätsklinikum St. Pölten, St. Pölten, Not set
Hanusch-Krankenhaus, Wien, Not set
Ziekenhuis Oost-Limburg, Campus St.-Jan, Genk, Limburg
UZ Gent, Gent, Oost-Vlaanderen
AZ Nikolaas, Sint-Niklaas, Oost-Vlaanderen
ZNA Cadix, Antwerpen, Not set
Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador, Salvador, Bahia
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, Rio Grande Do Sul
Instituto Joinvilense de Hematologia e Oncologia, Joinville, Santa Catarina
Hospital Amaral Carvalho, Jau, São Paulo
Americas Centro de Oncologia Integrado, Rio de Janeiro, Not set
Clínica Médica São Germano S/S Ltda, Sao Paulo, Not set
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Sao Paulo, Not set
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre, Greenfield Park, Quebec
Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎM) - Hôpital du Sacré-Coeur, Montreal, Quebec
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus, Quebec City, Quebec
Clínica Inmunocel, Santiago, Región Metropolitana De Santiago
Bradfordhill, Santiago, Región Metropolitana De Santiago
Centro de Investigaciones, Viña del Mar, Valparaíso
Beijing Chaoyang Hospital, Capital Medical University, Beijing City, Beijing
Local Institution - 0165, Beijing City, Beijing
Local Institution - 0141, Beijing, Beijing
The First Afffiliated Hospital of Chongqing Medical University, Chongqing, Chongqing
The First Affiliated hospital of Xiamen University, Xiamen, Fujian
Henan Cancer Hospital, Guangzhou, Guangdong
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
Local Institution - 0168, Guangzhou, Guangdong
Shenzhen Second People's Hospital, Shenzhen, Guangdong
Liuzhou Worker's Hospital - Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi
Guangxi Medical University No.1 Affiliated Hospital, Nanning, Guangxi
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei
The First Affiliated Hospital of Henan University of Science &Technology, Luoyang, Henan
People's Hospital of Henan Province, Zhengzhou, Henan
Wuhan Union Hospital, Wuhan, Hubei
Xiangya Hospital Central South University, Changsha, Hunan
The Third Xiangya Hospital of Central South University, Changsha, Hunan
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu
Wuxi People's Hospital, Wuxi, Jiangsu
Shengjing Hospital of China Medical University, Shenyang, Liaoning
The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'An, Shaanxi
Local Institution - 0110, Xi'an, Shaanxi
The Affiliated Hospital of Qingdao University, Qingdao, Shandong
Shanghai 6th people's hospital, Shanghai, Shanghai
Tongji University - Shanghai Fourth People's Hospital, Shanghai, Shanghai
First Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi
Local Institution - 0356, Deyang, Sichuan
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin
Local Institution - 0353, Urumqi, Xinjiang
First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan
Local Institution - 0151, Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang
Ningbo First Hospital, Ningbo, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang
Peking University First Hospital, Beijing, Not set
Shanxi Bethune Hospital, Taiyuan, Not set
Fakultní nemocnice Brno Bohunice, Brno, Brno-město
Fakultni nemocnice Kralovske Vinohrady, PRague, Praha 10
Vseobecna fakultni nemocnice v Praze, Praha, Not set
Kuopion Yliopistollinen Sairaala, Kuopio, Pohjois-Savo
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Not set
Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, Alsace
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
Hopital Claude Huriez - CHU de Lille, Lille, Nord
Centre Leon Berard, Lyon Cedex08, Rhône-Alpes
Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, Not set
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren, Limoges, Not set
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes, Not set
Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire Carémeau, Nîmes, Not set
Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau, Tours, Not set
Hôpital Saint Antoine, Paris, Île-de-France
TUM Klinikum, München, Bayern
Klinikum Traunstein, Traunstein, Bayern
Medizinisches Versorgungszentrum, Weiden, Bayern
Universitätsklinikum Marburg, Marburg, Hessen
Local Institution - 0414, Hannover, Niedersachsen
Universitätsklinikum Bonn, Bonn, Nordrhein-Westfalen
Local Institution - 0415, Düsseldorf, Nordrhein-Westfalen
Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein
Local Institution - 0396, Erfurt, Thüringen
Universitätsklinikum Aachen, Aachen, Not set
Sozialstiftung Bamberg, Bamberg, Not set
Gemeinschaftspraxis Hämatologie - Onkologie Freiberg-Richter, Jacobasch, Illmer, Wolf, Dresden, Not set
Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Not set
Asklepios Altona, Hamburg, Not set
Universitaetsklinikum Tuebingen, Tuebingen, Not set
Gemeinschaftspraxis Dres. med. Björn Schöttker & Dominik Pretscher, Würzburg, Not set
Evangelismos General Hospital of Athens, Athens, Attikí
Alexandra General Hospital of Athens, Athens, Attikí
G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki
HCG Aastha Cancer Centre, Ahmedabad, Gujarat
Marengo Asia Hospitals Gurugram, Gurugram, Haryana
KLES Dr. Prabhakar Kore Hospital & M.R.C, Belagavi, Karnataka
Local Institution - 0416, Mumbai, Maharashtra
Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu
Local Institution - 0341, Varanasi, Uttar Pradesh
Christian Medical College & Hospital, Ludhiana, Not set
Jawaharlal Institute Of Postgraduate Medical Education And Research, Puducherry, Not set
University College Hospital - Galway, Galway, Connaught
Cork University Hospital, Cork, Not set
St. James's Hospital, Dublin, Not set
Local Institution - 0251, Limerick, Not set
Meir Medical Center, Kfar Saba, HaMerkaz
Sheba Medical Center, Ramat Gan, HaMerkaz
Rambam Health Care Campus, Haifa, HaTsafon
Sourasky Medical Center, Tel Aviv, Tall Abīb
Hadassah Medical Center - Do Not Use - Duplicate Facility, Jerusalem, Yerushalayim
Rabin Medical Center, Peatch Tikva, Not set
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-Romagna
Policlinico "G. Rodolico", Catania, Sicilia
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set
Fondazione IRCCS Policlinico San Matteo, Pavia, Not set
Azienda Ospedaliera Sant'Andrea, Roma, Not set
National Cancer Center Hospital East, Kashiwa, Chiba
Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu-shi, Fukuoka
National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido
Local Institution - 0417, Ibarakimachi, Ibaraki
Iwate Medical University Hospital, Shiwa-gun Yahaba-cho, Iwate
Shonan Kamakura General Hospital, Kamakura, Kanagawa
Saitama Medical University Hospital, Iruma, Saitama
Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama
Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Shizuoka
Nihon University Itabashi Hospital, Itabashiku, Tokyo
Chiba University Hospital, Chiba, Not set
National Hospital Organization Kyushu Medical Center, Fukuoka, Not set
Japanese Red Cross Fukuoka Hospital, Fukuoka, Not set
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Not set
Kumamoto University, Kumamoto, Not set
The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Not set
The Jikei University Hospital, Tokyo, Not set
Japanese Red Cross Medical Center, Tokyo, Not set
Local Institution - 0106, Busan, Busan-gwangyeoksi
Pusan National University Hospital, Busan, Busan-gwangyeoksi
Local Institution - 0102, Seongnam, Gyeonggido
Seoul National University Bundang Hospital, Seongnam, Gyeonggido
Chonnam National University Hwasun Hospital, Hwasun, Jeonranamdo
Local Institution - 0103, Hwasun, Jeonranamdo
Local Institution - 0101, Seoul, Seoul Teugbyeolsi
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi
Samsung Medical Center, Seoul, Seoul Teugbyeolsi
Local Institution - 0104, Seoul, Seoul Teugbyeolsi
The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul Teugbyeolsi
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0105, Seoul, Seoul-teukbyeolsi
Local Institution - 0100, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Local Institution, Seoul, Not set
Tauranga Hospital, Tauranga, Bay Of Plenty
Dunedin Hospital, Dunedin, Otago
Auckland City Hospital, Auckland, Not set
Local Institution - 0334, Auckland, Not set
MICS Centrum Medyczne Torun, Torun, Kujawsko-pomorskie
Instytut Hematologii i Transfuzjologii, Warsaw, Mazowieckie
Local Institution - 0325, Kraków, Małopolskie
Local Institution - 0292, Słupsk, Pomorskie
Local Institution - 0346, Skórzewo, Wielkopolskie
Pratia Onkologia Katowice, Katowice, Not set
Hospital de Braga, Braga, Not set
Champalimaud Foundation, Lisbon, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set
Local Institution - 0355, San Juan, Not set
Fundeni Clinical Institute, Bucharest, Not set
Institutul Oncologic Cluj, Cluj Napoca, Not set
Institutul Regional de Oncologie Iasi, Iasi, Not set
Local Institution - 0405, Centurion, GP
Local Institution - 0404, Cape Town, Western Cape
Haemalife, Kuilsriver, Western Cape
Local Institution - 0406, Plumstead, Western Cape
Hospital Universitari Son Espases, Palma, Balears [Baleares]
Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña]
Local Institution - 0073, Barcelona, Catalunya [Cataluña]
Local Institution - 0183, Palma, Illes Balears
Hospital General Universitario Morales Meseguer, Murcia, Murcia, Región De
Hospital Costa del Sol, Marbella, Málaga
Local Institution - 0182, Marbella, Málaga
Hospital San Pedro de Alcantara, Cáceres, Not set
Complejo Asistencial Universitario de León - Hospital de León, León, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Ankara University Health Practice and Research Hospitals, Ankara, Not set
Liv Hospital Ankara, Ankara, Not set
Istanbul University, Istanbul Faculty of Medicine, Istanbul, Not set
Ege Universitesi Hastanesi, İzmir, Not set
Erciyes Universitesi Tıp Fakultesi Hastaneleri, Kayseri, Not set
Ondokuz Mayıs Universitesi, Samsun, Not set
Addenbrooke's Hospital, Cambridge, Cambridgeshire
The Royal Cornwall Hospital, Truro, England
Lanarkshire NHS Trust - Monklands Hospital, Airdrie, Great Britain
King's College Hospital, London, Greater London
Leicester Royal Infirmary, Leicester, Leicestershire
Hammersmith Hospital, London, London, City Of
Barnet Hospital, Barnet, Not set
Freeman Hospital, Newcastle upon Tyne, Not set
Royal Stoke University Hospital, Stoke-on-Trent, Not set
Conditions: Relapsed or Refractory Multiple Myeloma
13 - 24 of 187